Colorectal cancer has become the leading cause of cancer-related deaths among adults under age 50 in the United States, surpassing other major malignancies as overall cancer mortality in this age group continues to decline sharply, according to recent analyses from the American Cancer Society and published research.

Colorectal Cancer Now Leading Cause of Cancer Deaths in Americans
Colorectal Cancer Now Leading Cause of Cancer Deaths in Americans Under 50, New Data Show

A study released January 22, 2026, in the Journal of the American Medical Association examined U.S. cancer death trends from 1990 through 2023 for the five leading causes in people younger than 50. Researchers found that total cancer deaths in this demographic dropped 44 percent over the period, from 25.5 per 100,000 people in 1990 to 14.2 in 2023. Declines occurred in four of the top five causes — brain cancer (0.3 percent annual drop from 2014-2023), breast cancer (1.4 percent), leukemia (2.3 percent) and lung cancer (5.7 percent) — reflecting advances in prevention, early detection and treatment.

Colorectal cancer stood alone as an outlier. Mortality rose by an average of 1.1 percent annually since 2005, propelling it from the fifth-leading cause in the early 1990s to the top spot by 2023 — seven years earlier than some projections had anticipated. The disease now ranks first overall for cancer deaths under 50, second for women (behind breast cancer) and first for men.

"Overall progress against cancer in young adults has been remarkable, but colorectal cancer is moving in the wrong direction," said Rebecca L. Siegel, senior scientific director of surveillance research at the American Cancer Society and lead author of the JAMA research letter. "This confirms a real increase in underlying risk for generations born after about 1950."

The American Cancer Society's "Colorectal Cancer Statistics, 2026" report, published in March, reinforced the trend. It projected 158,850 new colorectal cancer cases and 55,230 deaths nationwide this year, with incidence rising 3 percent annually in adults aged 20-49 and 0.4 percent in those 50-64, while falling 2.5 percent in those 65 and older. Mortality has climbed 1 percent per year since 2004 in those under 50 and since 2019 in the 50-64 group.

The shift is driven largely by tumors in the distal colon and rectum. About one in five diagnoses now occurs in people under 55, up from far lower proportions decades ago. Younger patients are more likely to present with advanced-stage disease, contributing to poorer outcomes.

Experts attribute the rise to a mix of factors, though no single cause has been pinpointed. Potential contributors include changes in diet (higher processed foods, red meat and low fiber), sedentary lifestyles, obesity, diabetes, antibiotic use altering gut microbiomes and environmental exposures. Unlike older adults, where screening has driven steep declines, many under 50 lack routine checks, delaying diagnosis until symptoms like bleeding, pain or bowel changes appear — often dismissed as benign issues in younger people.

In response, major guidelines now recommend colorectal cancer screening starting at age 45 for average-risk adults, down from 50. Options include colonoscopy every 10 years, annual fecal immunochemical tests or stool DNA tests every three years. Uptake of non-invasive stool tests has risen, helping offset pandemic-related drops in colonoscopies.

The Colorectal Cancer Alliance called the findings a wake-up call, urging greater awareness, symptom education and involvement in research initiatives like Project Cure CRC to accelerate treatments.

Despite the alarming trend in young adults, overall U.S. colorectal cancer mortality has fallen 56 percent since 1970 due to screening, reduced smoking and better therapies. Yet progress has slowed recently, with rates stable from 2020-2023 after earlier annual declines of about 2 percent.

Advocates stress that many deaths could be prevented through earlier detection. Symptoms in younger people — persistent abdominal pain, unexplained weight loss, changes in bowel habits or rectal bleeding — warrant prompt medical attention, even if uncommon for the age group.

Ongoing research explores why incidence surges in post-1950 birth cohorts, with calls for more etiologic studies into modern lifestyle and environmental factors. As these generations age, the burden may grow without intervention.

Health organizations emphasize equity: screening gaps persist in underserved communities, where stool-based tests show promise for accessibility and cost.

The data highlight a paradox — broad success against cancer in young adults overshadowed by one disease's relentless rise. Experts urge clinicians to consider colorectal cancer in symptomatic patients under 50 and public campaigns to normalize screening discussions.

With March designated Colorectal Cancer Awareness Month, groups promote blue-ribbon campaigns to boost awareness and early action.

As the trend persists into 2026, the message remains clear: colorectal cancer is no longer just an older person's disease. Vigilance, lifestyle changes and timely screening offer the best defense against what has become the top cancer killer for Americans in their prime working and family years.